Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-03 03:32:31 - browse：73133

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

hotspot

WSS

A new deal aims to ramp up use of AI in rehab care decisions

New chart reveals military’s vast involvement in Operation Warp Speed

What is artificial intelligence? Experts weigh in

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

focus

Wikipedia

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Choosing scientific sides in the fight against Alzheimer's

Peter Hotez and the public health issue of online harassment

It's time to take a new tack for treating Alzheimer's

How one medical school became remarkably diverse

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

At least 13 dead in Texas as scorching temps continue

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Novavax promises a turnaround & Lilly roils the obesity market

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

explore

Florida babysitter arrested over hot car death, authorities say

Hey, doctors: Don't be no

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

FTX founder Sam Bankman

Hey, doctors: Don't be no

explore

entertainment

hotspot

hotspot